- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05606276
Effects of Eccentric Potentiation Activation on Muscle Function
April 19, 2024 updated by: Brennan Thompson
Effects of Multi-joint Eccentric Potentiation Maximal Contractions on Muscle Function
The purpose of this study is to examine the potentiation effects of 2 sets of multi-joint eccentric overload maximal contractions on muscle function.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Brennan J Thompson, PhD
- Phone Number: 435-881-0363
- Email: brennan.thompson@usu.edu
Study Contact Backup
- Name: Sara Harper, PhD
- Phone Number: 435-797-1376
- Email: sara.harper@usu.edu
Study Locations
-
-
Utah
-
Logan, Utah, United States, 84322
- Utah State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 28 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Exclusion Criteria:
- lower body surgery or injury in the last 12 months
- have any neuromuscular disease
- height >76 inches tall
- height <54 inches tall
- eccentric strength greater than 725 pounds
- pregnant or plan to be pregnant in the duration of the protocol
- don't do resistance exercise at least once per week
- perform intense cardio or strength training >4 days per week
- Present with any other significant comorbid conditions that would impair the ability to participate in the exercise-based testing
Inclusion criteria:
- 18 - 30 years old
- strength train lower body 1-3 times per week
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Cycling exercise
Cycling on a cycle ergometer instead of doing the experimental eccentric exercise.
|
Individuals will do a randomized crossover intervention involving cycling (active control) exercise
|
Experimental: Eccentric exercise
Perform 2 sets of maximal eccentric contractions as the single session exercise intervention.
|
Individuals will do a randomized crossover intervention involving maximal eccentric contractions (2 sets of 6 per leg; experimental condition)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vertical Jump
Time Frame: Baseline (pretest)
|
3 countermovement vertical jumps, with 30 seconds of rest between attempts
|
Baseline (pretest)
|
Vertical Jump
Time Frame: Immediately post intervention
|
3 countermovement vertical jumps, with 30 seconds of rest between attempts
|
Immediately post intervention
|
Vertical Jump
Time Frame: 12 minutes post intervention
|
3 countermovement vertical jumps, with 30 seconds of rest between attempts
|
12 minutes post intervention
|
Vertical Jump
Time Frame: 20 minutes post intervention
|
3 countermovement vertical jumps, with 30 seconds of rest between attempts
|
20 minutes post intervention
|
Isokinetic eccentric maximal strength
Time Frame: Baseline (pretest)
|
Maximal eccentric strength on the Eccentron machine. 2 repetitions per time point
|
Baseline (pretest)
|
Isokinetic eccentric maximal strength
Time Frame: Immediately post intervention
|
Maximal eccentric strength on the Eccentron machine. 2 repetitions per time point
|
Immediately post intervention
|
Isokinetic eccentric maximal strength
Time Frame: 12 minutes post intervention
|
Maximal eccentric strength on the Eccentron machine. 2 repetitions per time point
|
12 minutes post intervention
|
Isokinetic eccentric maximal strength
Time Frame: 20 minutes post intervention
|
Maximal eccentric strength on the Eccentron machine. 2 repetitions per time point
|
20 minutes post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Brennan J Thompson, PhD, Utah State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2022
Primary Completion (Actual)
March 1, 2024
Study Completion (Actual)
March 1, 2024
Study Registration Dates
First Submitted
October 24, 2022
First Submitted That Met QC Criteria
October 28, 2022
First Posted (Actual)
November 4, 2022
Study Record Updates
Last Update Posted (Actual)
April 23, 2024
Last Update Submitted That Met QC Criteria
April 19, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 12042c
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Activation Potentiation
-
Akebia TherapeuticsCompletedDrug Interaction PotentiationCanada
-
Il-Yang Pharm. Co., Ltd.CompletedDrug Interaction PotentiationKorea, Republic of
-
National Taiwan University HospitalCompletedDrug Interaction PotentiationTaiwan
-
Akebia TherapeuticsCompletedDrug Interaction PotentiationCanada
-
SK Chemicals Co., Ltd.CompletedDrug Interaction Potentiation
-
Tianjin Medical University General HospitalCompleted
-
Il-Yang Pharm. Co., Ltd.CompletedDrug Interaction PotentiationKorea, Republic of
-
F-star Therapeutics, Inc.PRA Health SciencesCompletedDrug Interaction PotentiationNetherlands
-
Akebia TherapeuticsCompletedDrug Interaction PotentiationCanada
-
LEO PharmaCompletedDrug Interaction PotentiationGermany
Clinical Trials on Cycle ergometer
-
Lakehead UniversityNorthern Ontario School of MedicineCompletedOsteoarthritis | Deep Venous ThrombosisCanada
-
Turku University HospitalUnknownGlymphatic System | NeurodegenerationFinland
-
Zhujiang HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)China
-
Universidade da CoruñaCompleted
-
Hospital de Clinicas de Porto AlegreCompleted
-
Zhujiang HospitalSun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Guangzhou Institute... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)China
-
Riphah International UniversityCompletedHeart Failure NYHA Class II | Heart Failure NYHA Class IPakistan
-
University of Sao PauloWithdrawnCardiac Surgery | Exercise Movement TechniquesBrazil
-
The Hong Kong Polytechnic UniversityRecruiting
-
Federal University of Health Science of Porto AlegreUnknownLymphoma | Leukemia | Fatigue | Multiple Myeloma | Hematopoietic Stem Cell TransplantationBrazil